Advanced search
Publication Cover
Acta Cardiologica Volume 77, 2022 - Issue 3
Submit an article Journal homepage
118
Views
3
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Predictive value of post-procedural hyponatremia on contrast-induced nephropathy in patients who underwent coronary angiography or percutaneous coronary intervention

Murat Gucuna Department of Nephrology, Kartal Kosuyolu Training and Research Hospital, Istanbul, Turkey
,
Muzaffer Kahyaoglub Department of Cardiology, Gaziantep Abdulkadir Yuksel State Hospital, Gaziantep, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8572-1725
ORCID Icon,
Mehmet Celikc Department of Cardiology, Kartal Kosuyolu Training and Research Hospital, Istanbul, Turkey
,
Ahmet Gunerd Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital, Istanbul, TurkeyORCID Iconhttps://orcid.org/0000-0001-6517-7278
ORCID Icon,
Okan Akyuze Department of Nephrology, Bilecik State Hospital, Bilecik, Turkey
&
Yusuf Yilmazf Department of Cardiology, Goztepe Training and Research Hospital, Istanbul, Turkey
Pages 215-221 | Received 25 Jan 2021, Accepted 05 Mar 2021, Published online: 25 May 2021

References

  • Hao J, Li Y, Zhang X, et al. The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study. BMC Nephrol. 2017;18(1):328.
  • Wald R, Jaber BL, Price LL, et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med. 2010;170(3):294–302.
  • Sturdik I, Adamcova M, Kollerova J, et al. Hyponatraemia is an independent predictor of in-hospital mortality. Eur J Intern Med. 2014;25(4):379–382.
  • Golestaneh L, Neugarten J, Kaskel F, et al. Progressive kidney disease may not alter the association of hyponatremia with mortality. Clin Exp Nephrol. 2018;22(4):889–897.
  • Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;100:11–15.
  • Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016;102(8):638–648.
  • Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936.
  • Lee WC, Fang HY, Fang CY. Tolvaptan rescue contrast-induced acute kidney injury: a case report. Medicine (Baltimore)). 2018;97(17):e0570–19.
  • Arroyo V, Rodés J, Gutiérrez-Lizárraga MA, et al. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis. 1976;21(3):249–256.
  • Sica DA. Hyponatremia and heart failure-pathophysiology and implications. Congest Heart Fail. 2005;11(5):274–277.
  • Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170:1–47.
  • Thomsen HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol. 2003;76(908):513–518.
  • Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555–562.
  • Hoorn EJ, Zietse R. Hyponatremia and mortality: moving beyond associations. Am J Kidney Dis. 2013;62(1):139–149.
  • Huang H, Jolly SE, Airy M, et al. Associations of dysnatremias with mortality in chronic kidney disease. Nephrol Dial Transplant. 2017;32:1204–1210.
  • Swart RM, Hoorn EJ, Betjes MG, et al. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. 2011;118(2):45–51.
  • Yin WJ, Yi YH, Guan XF, et al. Preprocedural prediction model for contrast-induced nephropathy patients. J Am Heart Assoc. 2017;6:1–11.
  • Toso A, Leoncini M, Maioli M, et al. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention). JACC Cardiovasc Interv. 2014;7(12):1421–1429.
  • Adrogué HJ. Hyponatremia in heart failure. Methodist Debakey Cardiovasc J. 2017;13(1):40.
  • Sirken G, Raja R, Garces J, et al. Contrast-induced translocational hyponatremia and hyperkalemia in advanced kidney disease. Am J Kidney Dis. 2004;44:1127.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.